title: Do we need another selective estrogen receptor modulator for the adjuvant treatment of breast cancer?
authors.forename: T
authors.initials: T
authors.lastname: Shenkier
references.citation: Cochrane Database Syst Rev. 2012 Jul 11;(7):CD008926
references.pmid: 22786516
references.citation: Int J Cancer. 2013 Mar 15;132(6):1475-85
references.pmid: 22915089
references.citation: Ann Oncol. 2004 Dec;15(12):1749-59
references.pmid: 15550579
references.citation: J Clin Oncol. 2000 Oct 15;18(20):3487-94
references.pmid: 11032589
references.citation: J Clin Oncol. 2013 Jan 10;31(2):176-80
references.pmid: 23091108
references.citation: Lancet. 2013 Mar 9;381(9869):805-16
references.pmid: 23219286
references.citation: Curr Oncol. 2013 Aug;20(4):196-204
references.pmid: 23904760
references.citation: J Natl Cancer Inst. 2012 Mar 21;104(6):427-8
references.pmid: 22395645
references.citation: J Clin Oncol. 2010 Aug 10;28(23):3784-96
references.pmid: 20625130
references.citation: Cancer. 2010 May 15;116(10):2307-15
references.pmid: 20209619
references.citation: Lancet. 2011 Aug 27;378(9793):771-84
references.pmid: 21802721